| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 2828431-88-3 | (2-((二甲基氨基)甲基)苯基)硼酸盐酸盐 | (2-((Dimethylamino)methyl)phenyl)boronic acid hydrochloride | C9H15BClNO2 | 215.48 | | |
| 2828431-89-4 | 3-(6-甲基吡啶-2-基)-N-苯基-4-(喹啉-4-基)-1H-吡唑-1-硫代甲酰胺钠盐 | 3-(6-Methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide, Sodium salt | C25H18N5NaS | 443.5 | | |
| 2828431-90-7 | (R)-2-氨基-2-(3,5-二氟吡啶-2-基)乙醇二盐酸盐 | (R)-2-Amino-2-(3,5-difluoropyridin-2-yl)ethanol dihydrochloride | C7H10Cl2F2N2O | 247.07 | | |
| 2828431-92-9 | (2R,3S)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 | (2R,3S)-3-(tert-butyl)-2-(di-tert-butylphosphino)-4-methoxy-2,3-dihydrobenzo[d][1,3]oxaphosphole | C20H34O2P2 | 368.43 | | 446.2±45.0 °C(Predicted) |
| 2828431-93-0 | rel-(3R,4S)-1-苄基-4-(2-甲氧基苯基)吡咯烷-3-羧酸甲酯盐酸盐 | Methyl rel-(3R,4S)-1-benzyl-4-(2-methoxyphenyl)pyrrolidine-3-carboxylate hydrochloride | C20H24ClNO3 | 361.863 | | |
| 2828431-94-1 | (E)-1,2-双(4-(1H-咪唑-1-基)苯基)-1,2-二苯乙烯 | (E)-1,2-Bis(4-(1H-imidazol-1-yl)phenyl)-1,2-diphenylethene | C32H24N4 | 464.56 | | 622.7±55.0 °C(Predicted) |
| 2828431-95-2 | (4R,4'R,5S,5'S)-2,2'-环丁亚基双[4,5-双-4,5-二苯基噁唑] | (4R,4'R,5S,5'S)-2,2'-(Cyclobutane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | C34H30N2O2 | 498.61 | | 631.5±55.0 °C(Predicted) |
| 2828431-96-3 | (4R,4'R)-2,2'-环丁亚基双[4,5-二氢-4-异丙基噁唑] | (4R,4'R)-2,2'-(Cyclobutane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole) | C16H26N2O2 | 278.38 | | 359.0±25.0 °C(Predicted) |
| 2828431-97-4 | (4R,4'R)-2,2'-环丁亚基双[4,5-二氢-4-叔丁基噁唑] | (4R,4'R)-2,2'-(Cyclobutane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) | C18H30N2O2 | 306.44 | | 377.5±25.0 °C(Predicted) |
| 2828431-98-5 | (4R,4'R)-2,2'-亚环戊基双[4-叔丁基-4,5-二氢噁唑] | (4R,4'R)-2,2'-(Cyclopentane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) | C19H32N2O2 | 320.47 | | 393.7±25.0 °C(Predicted) |
| 2828431-99-6 | (4R,4'R)-2,2'-亚环己基双[4,5-二氢-4-异丙基噁唑] | (4R,4'R)-2,2'-(Cyclohexane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole) | C18H30N2O2 | 306.44 | | |
| 2828432-00-2 | (4R,4'R)-2,2'-(环庚烷-1,1-二基)双(4-苄基-4,5-二氢噁唑) | (4R,4'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4-benzyl-4,5-dihydrooxazole) | C27H32N2O2 | 416.55 | | |
| 2828432-01-3 | (4R,4'R,5S,5'S)-2,2'-(环庚烷-1,1-二基)双(4,5-二苯基-4,5-二氢噁唑) | (4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | C37H36N2O2 | 540.690 | | |
| 2828432-02-4 | (4S,4'S,5R,5'R)-2,2'-(环庚烷-1,1-二基)双(4,5-二苯基-4,5-二氢噁唑) | (4S,4'S,5R,5'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | C37H36N2O2 | 540.69 | | 663.1±55.0 °C(Predicted) |
| 2828432-03-5 | (4R,4'R)-2,2'-(环庚烷-1,1-二基)双(4-异丙基-4,5-二氢噁唑) | (4R,4'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole) | C19H32N2O2 | 320.46 | | 407.6±28.0 °C(Predicted) |
| 2828432-04-6 | (4S,4'S)-2,2'-(环庚烷-1,1-二基)双(4-异丙基-4,5-二氢噁唑) | (4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole) | C19H32N2O2 | 320.46 | | |
| 2828432-05-7 | (4S,4'S)-2,2'-(环庚烷-1,1-二基)双(4-叔丁基-4,5-二氢噁唑) | (4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) | C21H36N2O2 | 348.53 | | 424.9±28.0 °C(Predicted) |
| 2828432-06-8 | (R)-4-异丙基-2-(4-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑 | (R)-4-Isopropyl-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole | C12H13F3N2O | 258.23 | | 328.3±42.0 °C(Predicted) |
| 2828432-07-9 | (R)-4-(叔丁基)-2-(4-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑 | (R)-4-(tert-Butyl)-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole | C13H15F3N2O | 272.26 | | 335.7±42.0 °C(Predicted) |
| 2828432-08-0 | (1Z,3Z)-1,3-二[[(4R)-4,5-二氢-4-苄基-2-噁唑基]亚甲基]-2,3-二氢-1H-异吲哚 | (1Z,3Z)-1,3-Bis(((R)-4-benzyl-4,5-dihydrooxazol-2-yl)methylene)isoindoline | C30H27N3O2 | 461.55 | | |
| 2828432-09-1 | (4S,4'S,5R,5'R)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基噁唑] | (4S,4'S,5R,5'R)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | C39H32N2O2 | 560.68 | | 692.2±55.0 °C(Predicted) |
| 2828432-10-4 | (4R,4'R)-2,2'-(戊烷-3,3-二基)双(4-甲基-4,5-二氢恶唑) | (4R,4'R)-2,2'-(Pentane-3,3-diyl)bis(4-methyl-4,5-dihydrooxazole) | C13H22N2O2 | 238.33 | | 306.8±25.0 °C(Predicted) |
| 2828432-12-6 | 2-(甲氧基甲氧基)-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)吡啶 | 2-(Methoxymethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C13H20BNO4 | 265.11 | | |
| 2828432-13-7 | (R)-4-(1-氨基乙基)-3-氟苯甲腈盐酸盐 | (R)-4-(1-Aminoethyl)-3-fluorobenzonitrile hydrochloride | C9H10ClFN2 | 200.64 | | |
| 2828432-14-8 | (R)-2-(2-((R)-(4-(叔丁基)苯基)亚磺酰基)苯基)-4-苯基-4,5-二氢恶唑 | (R)-2-(2-((R)-(4-(tert-Butyl)phenyl)sulfinyl)phenyl)-4-phenyl-4,5-dihydrooxazole | C25H25NO2S | 403.54 | | |
| 2828432-15-9 | (R)-4-苯基-2-(2-((R)-对甲苯亚磺酰基)苯基)-4,5-二氢恶唑 | (R)-4-Phenyl-2-(2-((R)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole | C22H19NO2S | 361.46 | | |
| 2828432-16-0 | (R)-1-(5-溴吡啶-2-基)乙胺x盐酸盐 | (R)-1-(5-Bromopyridin-2-yl)ethanamine xhydrochloride | C7H10BrClN2 | 237.52 | | |
| 2828432-18-2 | 3-(氮杂环丁烷-3-基)-1H-吡唑-5-胺盐酸盐 | 3-(Azetidin-3-yl)-1H-pyrazol-5-amine hydrochloride | C6H11ClN4 | 174.63 | | |
| 2828432-19-3 | 1-三氟乙酰基-4-苄胺基哌啶 | 1-(4-(Benzylamino)piperidin-1-yl)-2,2,2-trifluoroethan-1-one | C14H17F3N2O | 286.29 | | |
| 2828432-20-6 | (R)-4-苄基-2-(4-(三氟甲基)吡啶-2-基)-4,5-二氢恶唑 | (R)-4-Benzyl-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole | C16H13F3N2O | 306.28 | | 417.6±45.0 °C(Predicted) |
| 2828432-21-7 | (4S,5R)-2-(1,8-萘啶-2-基)-4,5-二苯基-4,5-二氢恶唑 | (4S,5R)-2-(1,8-Naphthyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole | C23H17N3O | 351.4 | | 553.5±50.0 °C(Predicted) |
| 2828432-23-9 | (4S,5R)-2-([2,2'-联吡啶]-6-基)-4,5-二苯基-4,5-二氢恶唑 | (4S,5R)-2-([2,2'-Bipyridin]-6-yl)-4,5-diphenyl-4,5-dihydrooxazole | C25H19N3O | 377.438 | | 581.3±50.0 °C(Predicted) |
| 2828432-25-1 | (S)-2-(2-(二苯基膦基)苯基)-4,5,5-三苯基-4,5-二氢恶唑 | (S)-2-(2-(Diphenylphosphanyl)phenyl)-4,5,5-triphenyl-4,5-dihydrooxazole | C39H30NOP | 559.64 | | |
| 2828432-26-2 | (R)-2-(2-(二苯基膦基)苯基)-4,5,5-三苯基-4,5-二氢恶唑 | (R)-2-(2-(Diphenylphosphanyl)phenyl)-4,5,5-triphenyl-4,5-dihydrooxazole | C39H30NOP | 559.64 | | |
| 2828432-27-3 | (4R,4'R)-2,2'-(1,3-二苯基丙烷-2,2-二基)双(4-(叔丁基)-4,5-二氢恶唑) | (4R,4'R)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) | C29H38N2O2 | 446.62 | | 549.6±50.0 °C(Predicted) |
| 2828432-28-4 | (4R,5S)-2-([2,2'-联吡啶]-6-基)-4,5-二苯基-4,5-二氢恶唑 | (4R,5S)-2-([2,2'-Bipyridin]-6-yl)-4,5-diphenyl-4,5-dihydrooxazole | C25H19N3O | 377.44 | | 581.3±50.0 °C(Predicted) |
| 2828432-29-5 | 2-氨基戊二酸二苄酯盐酸盐 | Dibenzyl 2-aminopentanedioate hydrochloride | C19H22ClNO4 | 363.84 | | |
| 2828432-30-8 | (R)-2-(2-(双(3,5-双(三氟甲基)苯基)膦基)苯基)-4-异丙基-4,5-二氢恶唑 | (R)-2-(2-(Bis(3,5-bis(trifluoromethyl)phenyl)phosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole | C28H20F12NOP | 645.42 | | 501.4±50.0 °C(Predicted) |
| 2828432-31-9 | 2-(环己烷甲酰胺基)-3-(1H-咪唑-4-基)丙酸盐酸盐 | 2-(Cyclohexanecarboxamido)-3-(1H-imidazol-4-yl)propanoic acid hydrochloride | C13H20ClN3O3 | 301.77 | | |
| 2828432-32-0 | 1-(4-(吡咯烷-1-羰基)苄基)肼甲酸叔丁酯 | tert-Butyl 1-(4-(pyrrolidine-1-carbonyl)benzyl)hydrazinecarboxylate | C17H25N3O3 | 319.4 | | 485.7±55.0 °C(Predicted) |
| 2828432-33-1 | 2,2',2''-(10-((4S,7S,13S)-14-((S)-2-(((2S,5S,8S,11S,14S)-8-(3-氨基-3-氧代丙基)-1-((S)-2-(((S)-1-(((S)-1-羧基-2-羟乙基)氨基)-4-甲基-1-氧代戊烷-2-基)氨基甲酰基)吡咯烷-1-基)-5-(羧甲基)-15-羟基-2-(羟甲基)-11-甲基-1,4,7,10,13-五氧代-3,6,9,12-四氮杂十五烷-14-基)氨基甲酰基)吡咯烷-1-基)-13-(羟甲基)-4,7-二异丙基-2,5,8,11,14-五氧代 | 2,2',2''-(10-((4S,7S,13S)-14-((S)-2-(((2S,5S,8S,11S,14S)-8-(3-Amino-3-oxopropyl)-1-((S)-2-(((S)-1-(((S)-1-carboxy-2-hydroxyethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-5-(carboxymethyl)-15-hydroxy-2-(hydroxymethyl)-11-methyl-1,4,7,10, | C68H112N18O28 | 1629.72 | | |
| 2828432-35-3 | 2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-咪唑-5-基)甲基)-19-((1H-吲哚-3-y基)甲基)-34-((2S,3S)-2-((R)-2-氨基-3-(4-羟基苯基)丙酰胺基)-3-甲基戊酰胺基)-4-(((2S,3S)-1-氨基-3-甲基-1-氧代戊-2-基)(甲基)氨基甲酰基)-25-(3-氨基-3-氧代丙基)-7-(3-胍基丙基)-31-异丙基-13,17-二甲基-28-((1-甲基-1H-吲哚-3-基)甲基)-6,9,12,15,1 | | C85H121N23O20S2 | 1849.14 | | |
| 2828432-36-4 | (3S,6S,9S,12S,21S,24S)-24-(2-氨基-2-氧代乙基)-12-(3-氨基-3-氧代丙基)-6-(4-氨基丁基)-9,21-双(羟甲基)-3-甲基-1,4,7,10,13,16,19,22-八氧代-1-((S)-5-氧代吡咯烷-2-基)-2,5,8,11,14,17,20,23-八氮杂二十五烷-25-酸三氟乙酸盐 | Nonathymulin trifluoroacetate | C35H55F3N12O17 | 972.88 | | |
| 2828432-37-5 | (S)-2-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S)-8-((1H-咪唑-5-基)甲基)-2,20,26-三(3-胍基丙基)-11-(羟甲基)-5,17,29-三异丁基-23-异丙基-14-甲基-4,7,10,13,16,19,22,25,28,31-十氧代-3,6,9,12,15,18,21,24,27,30-十氮杂三甲酰胺)-6-氨基-N-((4S,7S,10S,13S,16S,19S)-13-(4-氨基丁基)-4-氨基甲酰基-10,16-双(3-胍基丙基) | Cog 133 trifluoroacetate | C99H182F3N37O21 | 2283.73 | | |
| 2828432-38-6 | (H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2)2三氟乙酸盐 | (H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2)2 trifluoroacetate | C118H187F3N36O30S2 | 2711.096 | | |
| 2828432-39-7 | (S)-2-((S)-2-氨基-3-羟基丙胺基)-N-((2S,3S)-1-((2-(((S)-1-氨基-4-甲基-1-氧代戊烷-2-基)氨基)-5-胍基-1-氧代戊-2-基)氨基)-2-氧代乙基)氨基)-3-甲基-1-氧代戊-2-基)-4-甲基戊酰胺三氟乙酸盐 | Protease-Activated Receptor-2 Activating Peptide trifluoroacetate | C31H57F3N10O9 | 770.84 | | |
| 2828432-40-0 | (2S,5S,11S,14S,17S)-17-氨基-11-((S)-仲丁基)-5-(3-胍基丙基)-18-羟基-2,14-二异丁基-4,7,10,13,16-五氧代-3,6,9,12,15-五氮杂十八烷-1-油酸三氟乙酸盐 | H-Ser-Leu-Ile-Gly-Arg-Leu-OH trifluoroacetate | C31H56F3N9O10 | 771.83 | | |
| 2828432-41-1 | (S)-6-氨基-N-(2-(((2S,3S)-1-(((S)-1-(((S)-1-氨基-3-羟基-1-氧代丙-2-基)氨基)-4-甲基-1-氧代戊烷-2-基)氨基)-3-甲基-1-氧代戊烷-2-基)氨基)-2-氧代乙基)-2-((S)-2-氨基-3-甲基丁酰胺基)己酰胺 2,2,2-三氟乙酸酯 | (S)-6-Amino-N-(2-(((2S,3S)-1-(((S)-1-(((S)-1-amino-3-hydroxy-1-oxopropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-2-oxoethyl)-2-((S)-2-amino-3-methylbutanamido)hexanamide 2,2,2-trifluoroacetate | C30H55F3N8O9 | 728.8 | | |
| 2828432-42-2 | (S)-2-氨基-5-(((S)-1-羧基-2-苯乙基)氨基)-5-氧代戊酸三氟乙酸盐 | H-γ-Glu-Phe-OHtrifluoroacetate | C16H19F3N2O7 | 408.33 | | |
| 2828432-43-3 | (4R,7S,10S,13R,16S,19R)-13-((1H-吲哚-3-基)甲基)-N-((2S,3R)-1-氨基-3-羟基-1-氧代丁烷- 2-基)-19-((R)-2-氨基-3-苯基丙酰胺基)-10-(3-氨基丙基)-16-(4-羟基苄基)-7-((R)-1-羟乙基)-3,3-二甲基-6,9,12,15,18-五氧代-1,1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-羧酰胺三氟乙酸盐 | CTOP trifluoroacetate | C52H68F3N11O13S2 | 1176.29 | | |
m.cnreagent.com